Neuroloxía

2025

1. A head-to-head comparison of plasma biomarkers to detect Alzheimer's disease in a memory clinic

   Alzheimer's & dementia : the journal of the Alzheimer's Association, Vol. 21, Núm. 2, pp. e14609

2. Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study

   European Archives of Psychiatry and Clinical Neuroscience, Vol. 275, Núm. 1, pp. 257-266

3. Analysis of the accuracy of clinical diagnosis in an internal medicine department of a regional hospital: Inter-MONF study

   Journal of Healthcare Quality Research, Vol. 40, Núm. 5

4. Análisis Coste-Efectividad de una Unidad de ICTUS: Estudio del Caso del Complejo Hospitalario Universitario de Santiago de Compostela

   Revista de neurologia, Vol. 80, Núm. 2, pp. 39320

5. Assessing LDL-C Levels and Lipid-Modifying Therapies in a Real-World Cohort of Patients with Atherosclerotic Cardiovascular Disease: The REALITY Study

   Journal of Clinical Medicine, Vol. 14, Núm. 7

6. Association of oxygenation levels after successful mechanical thrombectomy under general anesthesia and 3-month functional outcome in patients with acute ischemic stroke: A prospective observational study

   Anaesthesia Critical Care and Pain Medicine, Vol. 44, Núm. 2

7. Blood DNA Methylation in Nuclear and Mitochondrial Sequences Links to Malnutrition and Poor Prognosis in ALS: A Longitudinal Study

   Nutrients , Vol. 17, Núm. 8

8. Blood Progenitor Cell Mobilization Driven by TWEAK Promotes Neovascularization and Reduces Brain Damage in a Rat Model of Intracerebral Hemorrhage

   Antioxidants, Vol. 14, Núm. 5

9. Blood-brain barrier leakage in renovascular hypertensive rats: A quantitative MRI analysis

   NeuroImage, Vol. 315

10. Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease in Spain

    Neurologia, Vol. 40, Núm. 3, pp. 290-305

11. Contribution of Blood Biomarkers to Multiple Sclerosis Diagnosis

    Neurology: Neuroimmunology and NeuroInflammation, Vol. 12, Núm. 2

12. Device-aided therapies (DATs) in Parkinson's disease (PD). The DATs-PD GETM Spanish Registry Protocol Study

    PLoS ONE, Vol. 20, Núm. 3 March

13. Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study

    Alzheimer's and Dementia, Vol. 21, Núm. 6

14. Dopamine agonist therapy in Parkinson's disease: Spanish expert consensus on its use in different clinical situations

    Neurologia, Vol. 40, Núm. 2, pp. 171-181

15. Dysphagia in Parkinson´s disease. A 5-year follow-up study

    Neurological Sciences, Vol. 46, Núm. 6, pp. 2637-2653

16. Effectiveness During 12-Month Adjunctive Brivaracetam Treatment in Patients with Focal-Onset Seizures in a Real-Life Setting: A Prospective, Observational Study in Europe

    Neurology and Therapy, Vol. 14, Núm. 2, pp. 627-642

17. Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real-world data study

    European Journal of Neurology, Vol. 32, Núm. 1

18. Elevated Serum Levels of Acid Sphingomyelinase in Female Patients with Episodic and Chronic Migraine

    Antioxidants, Vol. 14, Núm. 2

19. Fasudil inhibits α-synuclein aggregation through ROCK-inhibition-mediated mechanisms

    Neurotherapeutics, Vol. 22, Núm. 2

20. Health-Related Quality of Life and Cognitive Performance During 12-Month Adjunctive Brivaracetam Treatment in Patients with Focal-Onset Seizures: A Prospective, Observational Study in Europe

    Neurology and Therapy, Vol. 14, Núm. 2, pp. 609-625